Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medicinal cannabis driving and cognition crossover study
ACTRN12622001539729Phase 2Recruiting
- Sponsor
- Swinburne University of Technology
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dronabinol and cannabidiol (5 arms), sponsored by Swinburne University of Technology. Primary endpoints: Gaze transition entropy during driving, Standard deviation of lateral position during driving and 1 more. Started May 2023; status: recruiting.
02
Drugs
dronabinolcannabidiol
Beyond the preview
Go deeper on ACTRN12622001539729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622001539729.